Insights

Top brokers pick these 3 underperforming ASX shares as their latest buy idea

Value investors will increasingly need to look at the ASX dogs of FY21 to find bargains for the new financial…
The post Top brokers pick these 3 underperforming ASX shares as their latest buy idea appeared first on The Motley Fool Australia. –

Value investors will increasingly need to look at the ASX dogs of FY21 to find bargains for the new financial year, and three stand out as they are named the latest buys by leading brokers.

The fact is, the hunt for attractively-priced ASX shares is getting more difficult. The S&P/ASX 200 Index (Index:^AXJO) is sitting on a stellar gain of nearly 30%.

If it closes at these levels on June 30, it will mark its best performance in years.  

The ugly ducking could be a swan in FY22

Those sifting through the FY21 laggards for gems to pick up for the next 12-months might want to look at the A2 Milk Company Ltd (ASX: A2M) share price.

You’d be hard pressed to find a bigger dog. The A2 share price has taken a shocking shellacking and has shed more than 70% of its value over the past year.

But UBS is growing increasingly confident in its turnaround and reiterated its “buy” recommendation on the A2 share price.

Buy this ASX share as its glass is half full

“Average price for best seller a2 Platinum SKUs on major direct CBEC online platforms increased from CNY205/tin to CNY214/tin in April,” said UBS.

“At the same time, a2 Platinum share of best seller declined from 18% to 15% in April, but still remains above pre COVID-19 levels of 13%.

“We have also seen a sequential lift in Australian distributor pricing proxy for a2 Platinum. Collective, this is consistent with our analysis pointing to significant channel inventory tightening in 2HFY21.”

The broker’s 12-month price target on the A2 share price, which is also listed on the New Zealand stock exchange, is NZ$13.50.

Green shoots of earnings recovery

Meanwhile, the Nufarm Ltd (ASX: NUF) share price is another FY21 underperformer that got a tick of approval from Morgans.

The broker repeated its “add” recommendation on the Nufarm share price after the seeds and fertiliser group posted a better-than-expected result.

“NUF’s 1H21 result materially beat expectations as sales occurred earlier than normal given favourable operating conditions and COVID uncertainty/supply chain disruptions,” said Morgans.

“The strong result (EBITDA up 118% on pcp) was led by its ANZ, Europe and Seed Technologies businesses.”

The broker’s 12-month price target on the Nufarm share price is $6.50 a share.

Spoon full of sugar makes this ASX share a buy

One of the latest “buy” picks from Macquarie Group Ltd (ASX: MQG) is the Australian Pharmaceutical Industries Ltd (ASX: API) share price.

While the API share price is holding a 7% gain over the past year, that’s still way behind the broader market.

But Macquarie thinks this could soon change after it signed a non-exclusive deal to distribute Pfizer’s PBS medicines.

Pfizer distributes its medicines to over 5,600 pharmacies in Australia and the deal does not include Pfizer’s COVID-19 drug. But Macquarie thinks this could change if the government enlists the help of pharmacies to administer the vaccines.

Earnings upgrade

“API expects the additional volume provided by Pfizer Australia’s agreement will result in an uplift in EBIT of ~$4m p.a., which is an increase of +4.8% on our current FY22 estimates to ~$88m,” said Macquarie.

“API’s agreement with Pfizer’s will be generating a higher margin than its existing pharmacy distribution business.”

The broker’s 12-month price target on the API share price is $1.45 a share.

Where to invest $1,000 right now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

*Returns as of February 15th 2021

More reading

Why this expert is urging you to buy these ASX defensive shares even in a bull market

ASX 200 jumps, Qantas flies, Nufarm rises

Lower ASX 200 shares? The ground is moving on interest rates

2 excellent ASX 200 blue chip shares to buy

ASX 200 up 0.95%: Qantas update, Nufarm’s profits surge

The post Top brokers pick these 3 underperforming ASX shares as their latest buy idea appeared first on The Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;


To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.


An active and funded account with a positive trading balance is required to continue to have access to the tools;


Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;


Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!